 | • レポートコード：GIR-2104Z13891 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ダニ媒介性脳炎不活化ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ダニ媒介性脳炎不活化ワクチンの種類別市場規模（ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルス）、用途別市場規模（小児用ワクチン、成人用ワクチン、旅行者用ワクチン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ダニ媒介性脳炎不活化ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Encephalitis、Cochrane Collaboration、Sonic HealthPlus、Superdrug Health ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルス ・用途別分析2016年-2026年：小児用ワクチン、成人用ワクチン、旅行者用ワクチン ・ダニ媒介性脳炎不活化ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ダニ媒介性脳炎不活化ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ダニ媒介性脳炎不活化ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ダニ媒介性脳炎不活化ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ダニ媒介性脳炎不活化ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Tick-borne Encephalitis Inactivated Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Tick-borne Encephalitis Inactivated Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Tick-borne Encephalitis Inactivated Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Tick-borne Encephalitis Inactivated Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
European TBE Virus
Far Eastern TBE Virus
Siberian TBE Virus
Market segment by Application can be divided into
Pediatric Vaccines
Adult Vaccines
Traveler Vaccines
The key market players for global Tick-borne Encephalitis Inactivated Vaccine market are listed below:
Pfizer
Encephalitis
Cochrane Collaboration
Sonic HealthPlus
Superdrug Health
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Tick-borne Encephalitis Inactivated Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 European TBE Virus
1.2.3 Far Eastern TBE Virus
1.2.4 Siberian TBE Virus
1.3 Market Analysis by Application
1.3.1 Overview: Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pediatric Vaccines
1.3.3 Adult Vaccines
1.3.4 Traveler Vaccines
1.4 Global Tick-borne Encephalitis Inactivated Vaccine Market Size & Forecast
1.4.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales in Value (2016-2026))
1.4.2 Global Tick-borne Encephalitis Inactivated Vaccine Sales in Volume (2016-2026)
1.4.3 Global Tick-borne Encephalitis Inactivated Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity Analysis
1.5.1 Global Tick-borne Encephalitis Inactivated Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tick-borne Encephalitis Inactivated Vaccine Market Drivers
1.6.2 Tick-borne Encephalitis Inactivated Vaccine Market Restraints
1.6.3 Tick-borne Encephalitis Inactivated Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Tick-borne Encephalitis Inactivated Vaccine Product and Services
2.1.4 Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Encephalitis
2.2.1 Encephalitis Details
2.2.2 Encephalitis Major Business
2.2.3 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Product and Services
2.2.4 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Cochrane Collaboration
2.3.1 Cochrane Collaboration Details
2.3.2 Cochrane Collaboration Major Business
2.3.3 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Product and Services
2.3.4 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sonic HealthPlus
2.4.1 Sonic HealthPlus Details
2.4.2 Sonic HealthPlus Major Business
2.4.3 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Product and Services
2.4.4 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Superdrug Health
2.5.1 Superdrug Health Details
2.5.2 Superdrug Health Major Business
2.5.3 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Product and Services
2.5.4 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Tick-borne Encephalitis Inactivated Vaccine Sales by Manufacturer
3.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Tick-borne Encephalitis Inactivated Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Tick-borne Encephalitis Inactivated Vaccine Manufacturer Market Share
3.4.2 Top 6 Tick-borne Encephalitis Inactivated Vaccine Manufacturer Market Share
3.5 Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Tick-borne Encephalitis Inactivated Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size by Region
4.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2026)
4.2 North America Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026)
4.3 Europe Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026)
4.5 South America Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type (2016-2026)
5.3 Global Tick-borne Encephalitis Inactivated Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application (2016-2026)
6.3 Global Tick-borne Encephalitis Inactivated Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2026)
7.2 North America Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2026)
7.3 North America Tick-borne Encephalitis Inactivated Vaccine Market Size by Country
7.3.1 North America Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2026)
8.2 Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2026)
8.3 Europe Tick-borne Encephalitis Inactivated Vaccine Market Size by Country
8.3.1 Europe Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Market Size by Region
9.3.1 Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2026)
10.2 South America Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2026)
10.3 South America Tick-borne Encephalitis Inactivated Vaccine Market Size by Country
10.3.1 South America Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Market Size by Country
11.3.1 Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Tick-borne Encephalitis Inactivated Vaccine Typical Distributors
12.3 Tick-borne Encephalitis Inactivated Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Tick-borne Encephalitis Inactivated Vaccine Product and Services
Table 6. Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Encephalitis Basic Information, Manufacturing Base and Competitors
Table 8. Encephalitis Major Business
Table 9. Encephalitis Tick-borne Encephalitis Inactivated Vaccine Product and Services
Table 10. Encephalitis Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cochrane Collaboration Basic Information, Manufacturing Base and Competitors
Table 12. Cochrane Collaboration Major Business
Table 13. Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Product and Services
Table 14. Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sonic HealthPlus Basic Information, Manufacturing Base and Competitors
Table 16. Sonic HealthPlus Major Business
Table 17. Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Product and Services
Table 18. Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Superdrug Health Basic Information, Manufacturing Base and Competitors
Table 20. Superdrug Health Major Business
Table 21. Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Product and Services
Table 22. Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Tick-borne Encephalitis Inactivated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Tick-borne Encephalitis Inactivated Vaccine Production Site of Key Manufacturer
Table 28. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2016-2021e) & (K Units)
Table 29. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2021-2026) & (K Units)
Table 30. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021e) & (K Units)
Table 33. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units)
Table 34. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Tick-borne Encephalitis Inactivated Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Tick-borne Encephalitis Inactivated Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021e) & (K Units)
Table 39. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units)
Table 40. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Tick-borne Encephalitis Inactivated Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Tick-borne Encephalitis Inactivated Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021e) & (K Units)
Table 45. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units)
Table 46. North America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021e) & (K Units)
Table 49. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021e) & (K Units)
Table 51. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units)
Table 52. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units)
Table 54. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units)
Table 58. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units)
Table 68. South America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021e) & (K Units)
Table 69. South America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units)
Table 70. South America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021e) & (K Units)
Table 73. South America Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units)
Table 74. South America Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021e) & (K Units)
Table 75. South America Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Tick-borne Encephalitis Inactivated Vaccine Typical Distributors
Table 87. Tick-borne Encephalitis Inactivated Vaccine Typical Customers
List of Figures
Figure 1. Tick-borne Encephalitis Inactivated Vaccine Picture
Figure 2. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type in 2020
Figure 3. European TBE Virus
Figure 4. Far Eastern TBE Virus
Figure 5. Siberian TBE Virus
Figure 6. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application in 2020
Figure 7. Pediatric Vaccines
Figure 8. Adult Vaccines
Figure 9. Traveler Vaccines
Figure 10. Global Tick-borne Encephalitis Inactivated Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Tick-borne Encephalitis Inactivated Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Tick-borne Encephalitis Inactivated Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Tick-borne Encephalitis Inactivated Vaccine Sales (2016-2026) & (K Units)
Figure 32. Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity (2016-2026) & (K Units)
Figure 33. Global Tick-borne Encephalitis Inactivated Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Tick-borne Encephalitis Inactivated Vaccine Market Drivers
Figure 35. Tick-borne Encephalitis Inactivated Vaccine Market Restraints
Figure 36. Tick-borne Encephalitis Inactivated Vaccine Market Trends
Figure 37. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Manufacturer in 2020
Figure 38. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Manufacturer in 2020
Figure 39. Tick-borne Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Tick-borne Encephalitis Inactivated Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Tick-borne Encephalitis Inactivated Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region (2016-2026)
Figure 43. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region (2016-2026)
Figure 44. North America Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. South America Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2026)
Figure 50. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Type (2016-2026)
Figure 51. Global Tick-borne Encephalitis Inactivated Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Application (2016-2026)
Figure 54. Global Tick-borne Encephalitis Inactivated Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2026)
Figure 56. North America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2026)
Figure 57. North America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2026)
Figure 58. North America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2026)
Figure 59. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2026)
Figure 60. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2026)
Figure 61. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2026)
Figure 62. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2026)
Figure 67. South America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2026)
Figure 68. South America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2026)
Figure 69. South America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2026)
Figure 70. South America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の不活化ワクチン市場規模・現状・予測（2021年-2027年） Inactivated vaccines are viruses or bacteria that are first cultured and then inactivated with heat or chemicals. Inactivated vaccines may consist of whole viruses or bacteria, or they may consist of fragments that cleave together to form a cleaved vaccine. Market Analysis and Insights: Global Inact…- 世界のインフルエンザウイルスベクターワクチン市場規模・現状・予測（2021年-2027年） The virus-sensitive vector vaccine, which is characterized by nasal drip vaccination, is currently undergoing safety and efficacy studies in experimental animals. In 2021, the global Influenza Virus Vector Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the e…
- 世界の予防用B型肝炎ウイルスワクチン市場規模・現状・予測（2021年-2027年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 世界の脳炎ワクチン接種市場規模・現状・予測（2021年-2027年） Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s cla…
- 世界の脳炎ワクチン接種市場規模・現状・予測（2021年-2027年） Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s cla…